Journal for ImmunoTherapy of Cancer (Jan 2022)
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
- Kohei Taniguchi,
- Takuo Hayashi,
- Tomohito Tanaka,
- Kazuki Nishimura,
- Kyosuke Nishio,
- Kensuke Hirosuna,
- Kazumasa Komura,
- Wataru Fukuokaya,
- Ayako Ura,
- Taizo Uchimoto,
- Ko Nakamura,
- Tatsuo Fukushima,
- Yusuke Yano,
- Nobushige Takahashi,
- Keita Nakamori,
- Shoko Kinoshita,
- Tomohisa Matsunaga,
- Takeshi Tsutsumi,
- Takuya Tsujino,
- Hirofumi Uehara,
- Kiyoshi Takahara,
- Teruo Inamoto,
- Yoshinobu Hirose,
- Takahiro Kimura,
- Shin Egawa,
- Haruhito Azuma
Affiliations
- Kohei Taniguchi
- Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Takuo Hayashi
- Department of Human Pathology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
- Tomohito Tanaka
- Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Kazuki Nishimura
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Kyosuke Nishio
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Kensuke Hirosuna
- Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Kazumasa Komura
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Wataru Fukuokaya
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
- Ayako Ura
- Department of Human Pathology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
- Taizo Uchimoto
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Ko Nakamura
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Tatsuo Fukushima
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Yusuke Yano
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Nobushige Takahashi
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Keita Nakamori
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Shoko Kinoshita
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Tomohisa Matsunaga
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Takeshi Tsutsumi
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Takuya Tsujino
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Hirofumi Uehara
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Kiyoshi Takahara
- Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan
- Teruo Inamoto
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Yoshinobu Hirose
- Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- Takahiro Kimura
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
- Shin Egawa
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
- Haruhito Azuma
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
- DOI
- https://doi.org/10.1136/jitc-2021-003868
- Journal volume & issue
-
Vol. 10,
no. 1
Abstract
No abstracts available.